Vitamin D levels at birth and risk of type 1 diabetes in childhood: a case–control study

2015 ◽  
Vol 52 (6) ◽  
pp. 1077-1081 ◽  
Author(s):  
Francesco Cadario ◽  
Silvia Savastio ◽  
Veronica Pagliardini ◽  
Marco Bagnati ◽  
Matteo Vidali ◽  
...  
Bone Reports ◽  
2021 ◽  
Vol 14 ◽  
pp. 100869
Author(s):  
Tatiane Vilaca ◽  
Fatma Gossiel ◽  
Dinesh Selvarajah ◽  
Richard Eastell

2019 ◽  
Vol 20 (3) ◽  
pp. 330-338
Author(s):  
Julia Townson ◽  
Rebecca Cannings‐John ◽  
Nick Francis ◽  
Dan Thayer ◽  
John W. Gregory

2008 ◽  
Vol 79 ◽  
pp. S37
Author(s):  
Abdulbari Bener ◽  
Amer Alsaied ◽  
Maryam Ghanim Al-Ali ◽  
Marcellini Mian ◽  
Gerardo Guiter ◽  
...  

Children ◽  
2021 ◽  
Vol 8 (5) ◽  
pp. 419
Author(s):  
Carmen Muntean ◽  
Maria Săsăran

Vitamin D has emerged as a key factor in innate immunity. Its involvement in the pathogenesis of urinary tract infections (UTIs) has gained a lot of attention recently. The objective of this study is to investigate the association between serum 25-hydroxyvitamin D (25(OH)D) levels and first-time or recurrent UTIs in children. A prospective, case-control study was conducted on 101 pediatric patients, who were divided into two groups: 59 patients with UTIs and 42 age-matched healthy controls. Serum 25(OH)D was determined in each child and expressed in ng/mL. Vitamin D presented significantly lower values in study group subjects than in healthy controls (p < 0.01). Moreover, a significantly higher prevalence of vitamin D insufficiency and deficiency was found in children with UTIs (p < 0.01). Patients with recurrent UTIs presented significantly lower levels of vitamin D than those with first-time UTIs (p = 0.04). Urinary tract abnormalities did not seem to exercise an additional effect upon vitamin D levels within the study group. In conclusion, first-time and recurrent UTIs are associated with lower vitamin D levels. Further studies are necessary to validate our findings, as well as future longitudinal research regarding efficacy of vitamin D supplementation in children with UTIs.


2020 ◽  
Vol Volume 13 ◽  
pp. 759-765
Author(s):  
Ghadah Alhetheli ◽  
Ahmed Ibrahim Abd Elneam ◽  
Adel Alsenaid ◽  
Mohammed Al-Dhubaibi

Author(s):  
Shaimaa Reda Abdelmaksoud ◽  
Mostafa Abdel-Azim Mostafa ◽  
Rana Atef khashaba ◽  
Effat Assar

Objective The aim of the study is to investigate the relation of neonatal and maternal vitamin D and late-onset sepsis (LOS) Study Design One-hundred twenty term neonates along with their mothers were enrolled in this case–control study. Sixty neonates who were admitted in the neonatal intensive care unit by LOS and had not been previously admitted for last 48 hours and did not receive antibiotics or vitamin D were enrolled as cases (sepsis) group. On the other hand, 60 healthy term neonates were referred as control group. Maternal and neonatal serum 25-OH vitamin D levels were assessed in both the cohorts. Results Maternal and neonatal 25-OH vitamin D levels in cases (17.2 and 16.1 ng/mL, respectively) were significantly lower than in controls (22.7 and 21 ng/mL, respectively) p = 0.001. In the study group, the neonatal 25-OH vitamin D was negatively correlated with C-reactive protein and length of hospital stay (r = −0.616 and −0.596, respectively) p <0.001 for both. With a cut-off value of 12.9 ng/mL, the specificity and positive predictive value of neonatal vitamin D were 83.3 and 74.4%, respectively. The odds ratio was 1.088 (95% CI = 1.034–1.144)) for LOS in vitamin D-deficient neonates. Conclusion Neonates with higher vitamin D level are at lower risk of LOS than those with vitamin D deficiency. Maternal vitamin D correlates with neonatal vitamin D. These data suggest that maternal vitamin supplementation during pregnancy may lower the risk of LOS. Key Points


Sign in / Sign up

Export Citation Format

Share Document